Meglumine Diatrizoate 660mg + Sodium Diatrizoate 0.1gm
You Searched
₹948.2


WHO GMP
Certified

15 Days Easy
Returns

Long Expiry
(>8 Months)

WHO GMP
Certified

15 Days Easy
Returns

Long Expiry
(>8 Months)
In Diagnostic agent Trazograf 0.66gm/0.1gm Infusion contains radiopaque contrast mediums indicated for radiographic examination using x-rays. It helps for better visualisation of the parts where it is injected by a radiologist or a nurse and helps in diagnosing problems in the inside areas that are not visible to the naked eye. This enables the doctor to diagnose the underlying problem and helps to treat you better.
The majority of side effects typically do not necessitate medical intervention. and disappear as your body adjusts to the medicine. Doctor consultation is advised if they persist or if you're worried about them.
Your doctor or nurse will give you this medicine. Kindly do not self-administer.
Trazograf 0.66gm/0.1gm Infusion is a combination of two radioopaque contrast dyes. Meglumine Diatrizoate and Sodium Diatrizoate, when injected into the body through blood vessels it helps in scanning the internal organs and their functioning for an accurate diagnosis. Thus, helps in preventing future diseases.
Consult your Doctor: Please consult your doctor regarding the safety of consuming alcohol with Trazograf 0.66gm/0.1gm Infusion . Experts have not found evidence of alcohol impairing the effectiveness of the medicine.
Seek medical advice from your doctor: Trazograf 0.66gm/0.1gm Infusion may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Doctor consultation is advised.
Safe when prescribed by an expert: Trazograf 0.66gm/0.1gm Infusion is probably safe to use during breastfeeding. Limited human data suggests that the drug does not represent any significant risk to the baby.
Seek medical advice from your doctor: It is not known whether Trazograf 0.66gm/0.1gm Infusion alters the ability to drive. Do not drive if you experience any symptoms that affect your ability to concentrate and react.
Seek medical advice from your doctor: There is limited information available on the use of Trazograf 0.66gm/0.1gm Infusion in patients with kidney disease. Doctor consultation is advised.
Seek medical advice from your doctor: There is limited information available on the use of Trazograf 0.66gm/0.1gm Infusion in patients with liver disease. Doctor consultation is advised.
Cnergy IT Park, 3rd floor Appa Saheb Marathe Marg, Prabhadevi, Mumbai 400025
DailyMed. Meglumine Diatrizoate (04 Apr. 2019)
PlatinumRx is dedicated to delivering dependable and trustworthy information to empower our customers. However, the information presented here is solely for general informational purposes and should not be utilized for diagnosing, preventing, or treating health issues. It is not intended to establish a doctor-patient relationship or serve as a substitute for professional medical advice.
Flat Rs 100 on first app order | Use Code: APP100 |
Flat Rs 100 on first app order
USE CODE: APP100

Download Now